HM13
Basic information
Region (hg38): 20:31514428-31577923
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HM13 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 27 | 27 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 27 | 0 | 0 |
Variants in HM13
This is a list of pathogenic ClinVar variants found in the HM13 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-31514570-G-A | not specified | Uncertain significance (Apr 23, 2024) | ||
20-31514576-C-T | not specified | Uncertain significance (Oct 06, 2024) | ||
20-31514583-G-T | not specified | Uncertain significance (Jun 24, 2022) | ||
20-31514592-A-T | not specified | Uncertain significance (May 27, 2022) | ||
20-31514598-G-A | not specified | Uncertain significance (Aug 12, 2024) | ||
20-31514624-C-T | not specified | Uncertain significance (Nov 01, 2022) | ||
20-31514646-T-C | not specified | Uncertain significance (Apr 26, 2023) | ||
20-31514672-C-T | not specified | Uncertain significance (Jun 03, 2022) | ||
20-31527538-A-G | not specified | Uncertain significance (Dec 15, 2023) | ||
20-31538239-C-G | not specified | Uncertain significance (Apr 17, 2024) | ||
20-31544988-G-A | not specified | Uncertain significance (Sep 26, 2023) | ||
20-31545017-T-G | not specified | Uncertain significance (Jul 31, 2023) | ||
20-31545020-G-A | not specified | Uncertain significance (Nov 07, 2022) | ||
20-31549088-G-A | not specified | Uncertain significance (Oct 30, 2023) | ||
20-31549094-G-A | not specified | Uncertain significance (Feb 22, 2023) | ||
20-31549110-G-A | not specified | Uncertain significance (Jan 04, 2022) | ||
20-31554773-A-G | not specified | Uncertain significance (Mar 25, 2024) | ||
20-31566248-T-G | not specified | Uncertain significance (Oct 25, 2023) | ||
20-31566250-C-T | not specified | Uncertain significance (Dec 22, 2023) | ||
20-31566288-A-C | not specified | Uncertain significance (Oct 16, 2023) | ||
20-31568092-C-T | not specified | Uncertain significance (Jul 17, 2024) | ||
20-31568163-G-A | not specified | Uncertain significance (Oct 01, 2024) | ||
20-31568176-A-C | not specified | Uncertain significance (Jan 03, 2024) | ||
20-31568196-C-T | not specified | Uncertain significance (Jul 27, 2024) | ||
20-31568203-G-A | not specified | Uncertain significance (Aug 28, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HM13 | protein_coding | protein_coding | ENST00000398174 | 13 | 55140 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.690 | 0.310 | 125735 | 0 | 13 | 125748 | 0.0000517 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.09 | 151 | 243 | 0.622 | 0.0000135 | 2751 |
Missense in Polyphen | 13 | 50.048 | 0.25975 | 591 | ||
Synonymous | 1.38 | 90 | 108 | 0.831 | 0.00000659 | 873 |
Loss of Function | 3.48 | 4 | 21.3 | 0.188 | 9.75e-7 | 243 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000125 | 0.000122 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000110 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000178 | 0.0000176 |
Middle Eastern | 0.000110 | 0.000109 |
South Asian | 0.000197 | 0.000196 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes intramembrane proteolysis of some signal peptides after they have been cleaved from a preprotein, resulting in the release of the fragment from the ER membrane into the cytoplasm. Required to generate lymphocyte cell surface (HLA-E) epitopes derived from MHC class I signal peptides (PubMed:11714810). May be necessary for the removal of the signal peptide that remains attached to the hepatitis C virus core protein after the initial proteolytic processing of the polyprotein (PubMed:12145199). Involved in the intramembrane cleavage of the integral membrane protein PSEN1 (PubMed:12077416, PubMed:11714810, PubMed:14741365). Cleaves the integral membrane protein XBP1 isoform 1 in a DERL1/RNF139-dependent manner (PubMed:25239945). May play a role in graft rejection (By similarity). {ECO:0000250|UniProtKB:Q9D8V0, ECO:0000269|PubMed:11714810, ECO:0000269|PubMed:12077416, ECO:0000269|PubMed:12145199, ECO:0000269|PubMed:14741365, ECO:0000269|PubMed:25239945}.;
Recessive Scores
- pRec
- 0.222
Intolerance Scores
- loftool
- 0.343
- rvis_EVS
- -0.43
- rvis_percentile_EVS
- 25.15
Haploinsufficiency Scores
- pHI
- 0.294
- hipred
- Y
- hipred_score
- 0.728
- ghis
- 0.511
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.958
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- H13
- Phenotype
- homeostasis/metabolism phenotype; craniofacial phenotype; muscle phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; embryo phenotype; renal/urinary system phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype; limbs/digits/tail phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; neoplasm; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); liver/biliary system phenotype; respiratory system phenotype;
Gene ontology
- Biological process
- signal peptide processing;membrane protein ectodomain proteolysis;membrane protein intracellular domain proteolysis;membrane protein proteolysis;protein homotetramerization;membrane protein proteolysis involved in retrograde protein transport, ER to cytosol
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;rough endoplasmic reticulum;plasma membrane;cell surface;membrane;Derlin-1 retrotranslocation complex;integral component of cytoplasmic side of endoplasmic reticulum membrane;integral component of lumenal side of endoplasmic reticulum membrane
- Molecular function
- protein binding;peptidase activity;ubiquitin protein ligase binding;aspartic endopeptidase activity, intramembrane cleaving;protein homodimerization activity